Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?

Background To investigate baseline demographics and disease characteristics as predictors of the analgesic effect of duloxetine and pregabalin on diabetic peripheral neuropathic pain (DPNP). Methods Based on data from the COMBO‐DN study, a multinational clinical trial in DPNP, the potential impact o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of pain 2016-03, Vol.20 (3), p.472-482
Hauptverfasser:	Marchettini, P., Wilhelm, S., Petto, H., Tesfaye, S., Tölle, T., Bouhassira, D., Freynhagen, R., Cruccu, G., Lledó, A., Choy, E., Kosek, E., Micó, J.A., Späth, M., Skljarevski, V., Lenox-Smith, A., Perrot, S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Affect Age Factors Aged Analgesics - adverse effects Analgesics - therapeutic use Anticonvulsants - adverse effects Anticonvulsants - therapeutic use Antidepressive Agents - adverse effects Antidepressive Agents - therapeutic use Anxiety - complications Anxiety - psychology Depression - complications Depression - psychology Diabetic Neuropathies - complications Diabetic Neuropathies - drug therapy Diabetic Neuropathies - psychology Duloxetine Hydrochloride - adverse effects Duloxetine Hydrochloride - therapeutic use Female Humans Male Middle Aged Pain - drug therapy Pain - psychology Pregabalin - adverse effects Pregabalin - therapeutic use Psychiatric Status Rating Scales Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!